|
|
|
Sunday, February 27, 2011 — 7:30 p.m. — CC 103 A/B
|
- Update of Estrogen Receptor Positive Breast Cancer: Receptor Evaluation, Molecular Classification and Mechanisms of Resistance
|
|
Moderator:
|
Juan Palazzo, Jefferson University, Philadelphia, PA
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. The speakers listed below have indicated they have nothing to disclose.
|
Click the button above to add this event to your Itinerary Planner...
 Click here to view (or print) handout in single page format for the entire meeting.
Note: Any slides will be printed in color.
Click here to view (or print) black and white handout for the entire meeting
Note: Text will be in single page format and any slides will be in 6-per-page format.
Click any blue title below to display and print the handout for individual lecture(s):
| Evaluating Hormone Receptors in Breast Cancer: Past, Present, and Future
- D. Craig Allred, Washington University School of Medicine, St. Louis, MO |
| Resistance to Endocrine Therapy of Breast Cancer: Mechanisms and Clinical Implications
- C. Kent Osborne, Baylor College of Medicine, Houston, TX |
| Molecular Classification of ER Positive (Luminal) Cancers
- Jorge Reis-Filho, The Breakthrough Breast Cancer Research Center/
Institute of Cancer Research, London, UK |
|
|
|
